[1]Yu MC,JM Yuan.Epidemiology of nasopharyngeal carcinoma[J].Semin Cancer Biol,2002,12(6):421-429.
[2]Gupta PB,Onder TT,Jiang G,et al.Identification of selective inhibitors of cancer stem cells by high-throughput screening[J].Cell,2009,138(4):645-659.
[3]Zhang Z,Zhao J,Mi Z,et al.Effects of salinomycin and 17AAG on proliferation of human gastric cancer cells in vitro[J].Mol Med Rep,2017,16(2):1063-1070.
[4]Dosch JS,Ziemke EK,Shettigar A,et al.Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer[J].Cancer Res,2015,75(21):4582-4592.
[5]Tung CL,Chen JC,Wu CH,et al.Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells[J].Exp Cell Res,2017,357(1):59-66.
[6]Liffers ST,Tilkorn DJ,Stricker I,et al.Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas[J].BMC Cancer,2013,13:490.
[7]Kim JH,Yoo HI,Kang HS,et al.Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest[J].Biochem Biophys Res Commun,2012,418(1):98-103.
[8]Kim WK,Kim JH,Yoon K,et al.Salinomycin,a p-glycoprotein inhibitor,sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest[J].Invest New Drugs,2012,30(4):1311-1318.
[9]Wang F,He L,Dai WQ,et al.Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo[J].PLoS One,2012,7(12):e50638
[10]Wang F,Dai W,Wang Y,et al.The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma[J].PLoS One,2014,9(5):e97414.
[11]Lieke T,Ramackers W,Bergmann S,et al.Impact of Salinomycin on human cholangiocarcinoma:Induction of apoptosis and impairment of tumor cell proliferation in vitro[J].BMC Cancer,2012,12:466.
[12]Naujokat C,R Steinhart.Salinomycin as a drug for targeting human cancer stem cells[J].J Biomed Biotechnol,2012,20(12):e950658.
[13]Wu DX,Wang SM,Zhang JR,et al.Effect of salinomycin on the proliferation and apoptosis of nasopharyngeal carcinoma CNE-2 cell line[J].Journal of Practical Medicine,2013,29(24):3967-3970.[吴丹心,汪森明,张积仁,等.盐霉素诱导鼻咽癌CNE-2细胞凋亡及其作用机制的探讨[J].实用医学杂志,2013,29(24):3967-3970.]
[14]Callaway TR,Edrington TS,Rychlik JL,et al.Ionophores:Their use as ruminant growth promotants and impact on food safety[J].Curr Issues Intest Microbiol,2003,4(2):43-51.
[15]Fuchs D,Heinold A,Opelz G,et al.Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells[J].Biochem Biophys Res Commun,2009,390(3):743-749.
[16]Daman Z,Montazeri H,Azizi M,et al.Polymeric micelles of PEG-PLA copolymer as a carrier for salinomycin against gemcitabine-resistant pancreatic cancer[J].Pharm Res,2015,32(11):3756-3767.
[17]Zhou J,Li P,Xue X,et al.Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species[J].Toxicol Lett,2013,222(2):139-145.
[18]Ketola K,Hilvo M,Hyotylainen T,et al.Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress[J].Br J Cancer,2012,106(1):99-106.
[19]Kusunoki Soshi,Kato Kiyoko,Tabu Kouichi,et al.The inhibitory effect of salinomycin on the proliferation,migration and invasion of human endometrial cancer stem-like cells[J].Gynecologic Oncology,2013,129(3):598-605.
[20]Yu SM,SJ Kim.Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase,ERK-1/2 and p38 kinase pathways[J].Int J Oncol,2016,48(6):2686-2692.
[21]Hanrahan K,O'Neill A,Prencipe M,et al.The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer[J].Mol Oncol,2017,11(3):251-265.
[22]Kuo SZ,Blair KJ,Rahimy E,et al.Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt[J].BMC Cancer,2012,12:556.
[23]Pawlik TM,K Keyomarsi.Role of cell cycle in mediating sensitivity to radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,59(4):928-942.